SM

Supriya Mohanty

Active Director Director DIN 03410005
DIN 03410005 First appointment Feb 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Feb 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Supriya Mohanty

Data last updated:

Supriya Mohanty is a Director at Candaur Pharmaceuticals Private Limited (since 2015) and Director at Rytus Healthcare Private Limited (since 2011). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Candaur Pharmaceuticals Private Limited at ₹6.79 Cr (FY 2025). Earlier, Supriya Mohanty was a Director at Rytus Therapeutics Limited (2011–2021).

DIN 03410005
Primary Designation Director
Industry Pharma
First Appointment 21 Feb 2011
Oldest Company Age 21 yrs
Largest company Candaur Pharmaceuticals Private Limited Β· ₹6.79 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20152005₹6.79 Cr (FY 2025)Active
Rytus Healthcare Private Limited U88900MH2011PTC219910
Director18 Jul 20112011Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rytus Therapeutics Limited U24100MH2011PLC213828
Director21 Feb 20112011₹1.42 Cr (FY 2015)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Candaur Pharmaceuticals Private Limited
Rytus Healthcare Private Limited
Rytus Therapeutics Limited
Premium access

Shareholding and investment profile for Supriya Mohanty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Supriya Mohanty

Supriya Mohanty currently holds 2 directorships: Candaur Pharmaceuticals Private Limited (Director, since 01 Jul 2015, revenue β‚Ή6.79 Cr (FY 2025)); Rytus Healthcare Private Limited (Director, since 18 Jul 2011).

Supriya Mohanty was first appointed on 21 Feb 2011 as Director at Rytus Therapeutics Limited. The most recent appointment on record is 01 Jul 2015 at Candaur Pharmaceuticals Private Limited.

Supriya Mohanty held 1 earlier board appointment: Rytus Therapeutics Limited (Director, 21 Feb 2011 to 01 Dec 2021).

The current boards of Supriya Mohanty's companies include Geetika Gupta (Candaur Pharmaceuticals Private Limited), Manas Ranjan Patnaik (Candaur Pharmaceuticals Private Limited), Pragyan Paramita Patnaik (Candaur Pharmaceuticals Private Limited), Abhinna Mohanty Sundar (Rytus Healthcare Private Limited), Anand Mohanty Swaroop (Rytus Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available